相似文献
1
Targeted synthesis of 1-(4-hydroxyiminomethylpyridinium)-3-pyridiniumpropane dibromide--a new nerve agent reactivator.
Molecules. 2007 Aug 20;12(8):1964-72. doi: 10.3390/12081964.
2
In vitro reactivation of tabun-inhibited acetylcholinesterase using new oximes--K027, K005, K033 and K048.
Cent Eur J Public Health. 2004 Mar;12 Suppl:S59-61.
3
Design of a potent reactivator of tabun-inhibited acetylcholinesterase--synthesis and evaluation of (E)-1-(4-carbamoylpyridinium)-4-(4-hydroxyiminomethylpyridinium)-but-2-ene dibromide (K203).
J Med Chem. 2007 Nov 1;50(22):5514-8. doi: 10.1021/jm070653r. Epub 2007 Oct 9.
4
In vitro reactivation of acetylcholinesterase inhibited by cyclosarin using bisquaternary pyridinium aldoximes K005, K033, K027 AND K048.
Acta Medica (Hradec Kralove). 2004;47(2):107-9.
5
In vitro reactivation of acetylcholinesterase using the oxime K027.
Vet Hum Toxicol. 2004 Feb;46(1):15-8.
6
New quaternary pyridine aldoximes as casual antidotes against nerve agents intoxications.
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005 Jun;149(1):75-82. doi: 10.5507/bp.2005.008.
7
In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Toxicology. 2006 Feb 15;219(1-3):85-96. doi: 10.1016/j.tox.2005.11.003. Epub 2005 Dec 5.
8
A comparison of reactivating efficacy of newly developed oximes (K074, K075) and currently available oximes (obidoxime, HI-6) in cyclosarin-and tabun-poisoned rats.
J Enzyme Inhib Med Chem. 2007 Jun;22(3):297-300. doi: 10.1080/14756360601114361.
9
Monooxime reactivators of acetylcholinesterase with (E)-but-2-ene linker: preparation and reactivation of tabun- and paraoxon-inhibited acetylcholinesterase.
Bioorg Med Chem. 2007 Nov 1;15(21):6733-41. doi: 10.1016/j.bmc.2007.08.002. Epub 2007 Aug 10.
10
Oxime K027: novel low-toxic candidate for the universal reactivator of nerve agent- and pesticide-inhibited acetylcholinesterase.
J Enzyme Inhib Med Chem. 2010 Aug;25(4):509-12. doi: 10.3109/14756360903357569.
引用本文的文献
1
Differential binding of bispyridinium oxime drugs with acetylcholinesterase.
Acta Pharmacol Sin. 2010 Mar;31(3):313-28. doi: 10.1038/aps.2009.193. Epub 2010 Feb 8.
2
Effect of seven newly synthesized and currently available oxime cholinesterase reactivators on cyclosarin-intoxicated rats.
Int J Mol Sci. 2009 Jul 7;10(7):3065-3075. doi: 10.3390/ijms10073065.
本文引用的文献
1
Evaluation of newly synthesized reactivators of the brain cholinesterase inhibited by sarin nerve agent.
Toxicol Mech Methods. 2005;15(4):247-52. doi: 10.1080/15376520590968770.
2
Treatment of organophosphate intoxication using cholinesterase reactivators: facts and fiction.
Mini Rev Med Chem. 2007 May;7(5):461-6. doi: 10.2174/138955707780619581.
3
Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3172-6. doi: 10.1016/j.bmcl.2007.03.025. Epub 2007 Mar 13.
4
Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterases.
J Enzyme Inhib Med Chem. 2006 Dec;21(6):663-6. doi: 10.1080/14756360600850916.
5
Health and environmental threats associated with the destruction of chemical weapons.
Ann N Y Acad Sci. 2006 Sep;1076:549-58. doi: 10.1196/annals.1371.069.
6
Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
Toxicology. 2007 Apr 20;233(1-3):108-19. doi: 10.1016/j.tox.2006.08.033. Epub 2006 Sep 1.
7
Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Toxicology. 2006 Nov 10;228(1):41-50. doi: 10.1016/j.tox.2006.08.012. Epub 2006 Aug 18.
8
Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.
Toxicology. 2007 Apr 20;233(1-3):85-96. doi: 10.1016/j.tox.2006.08.003. Epub 2006 Aug 7.
9
A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods.
J Toxicol Environ Health A. 2006 Oct;69(20):1875-82. doi: 10.1080/15287390600631730.
10
Development of antidotes: problems and strategies.
Toxicology. 2007 Apr 20;233(1-3):23-30. doi: 10.1016/j.tox.2006.07.008. Epub 2006 Jul 14.
Zotero 插件